Table III.
Comparison of clinical parameters before and after intervention between VATS and streptokinase groups
Variable | VATS group (n = 28) | Streptokinase group (n = 18) | P-value |
---|---|---|---|
Before intervention: | |||
Illness duration [days] mean ± SD | 8.5 ±2.8 | 8.0 ±2.4 | 0.514a |
AB therapy [days] mean ± SD | 6.3 ±2.2 | 7.3 ±2.2 | 0.140a |
After intervention | |||
Hospital stay [days] mean ± SD | 2.8 ±1.7 | 7.5 ±3.5 | < 0.001a |
Days with fever [days] mean ± SD | 1.9 ±0.7 | 3.0 ±1.6 | 0.017a |
Days with drainage [days] mean ± SD | 3.0 ±1.6 | 7.5 ±4.4 | < 0.001a |
Outcome, n (%): | 0.042b | ||
Success | 26 (92.9) | 12 (66.7) | |
Failure | 2 (7.1) | 6 (33.3) |
P-value of < 0.05 was considered statistically significant.
Independent t test,
Fisher exact test.